| |
| |
|
| Insider
Information: |
Raines Merilee |
| Relationship: |
|
| City: |
Westbrook |
| State: |
ME |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
93,944 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,451,895 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
93,944 |
|
|
| Total
Value |
$18,451,895 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idexx Laboratories Inc |
IDXX |
Executive VP & CFO |
2013-02-25 |
26,577 |
2013-02-01 |
0 |
Premium* |
|
|
Watts Industries Inc |
WTS |
Director |
2023-07-31 |
20,020 |
2011-03-01 |
0 |
Premium* |
|
|
Affymetrix Inc |
AFFX |
Director |
2016-03-31 |
0 |
2015-05-13 |
0 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
Director |
2019-07-18 |
0 |
2016-06-24 |
0 |
Premium* |
|
|
Benchmark Electronics Inc |
BHE |
Director |
2021-05-12 |
24,489 |
2019-05-15 |
0 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
Director |
2023-06-14 |
20,933 |
2022-06-16 |
0 |
Premium* |
|
|
Transmedics Group, Inc. |
TMDX |
|
2024-05-23 |
1,925 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IDXX |
Idexx Laboratories Inc |
VP & CFO |
• – – |
2005-05-03 |
4 |
OE |
$22.50 |
$144,000 |
D/D |
6,400 |
22,100 |
|
- |
|
| IDXX |
Idexx Laboratories Inc |
officerTitle |
• – – |
2006-01-31 |
4 |
S |
$77.00 |
$539,009 |
D/D |
(7,000) |
35,200 |
|
- |
|
| AFFX |
Affymetrix Inc |
Director |
– • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,579 |
7,579 |
0 |
- |
|
| AFFX |
Affymetrix Inc |
Director |
– • – |
2016-03-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,579) |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-08-08 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
178,747 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-08-08 |
4 |
AS |
$88.77 |
$686,389 |
D/D |
(7,726) |
171,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-09-12 |
4 |
AS |
$98.29 |
$759,368 |
D/D |
(7,726) |
171,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-09-12 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
178,747 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-10-10 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
178,747 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-10-10 |
4 |
AS |
$96.08 |
$742,313 |
D/D |
(7,726) |
171,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-11-14 |
4 |
AS |
$89.91 |
$697,449 |
D/D |
(7,726) |
146,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-11-14 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
153,747 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-12-12 |
4 |
AS |
$94.86 |
$738,416 |
D/D |
(7,726) |
146,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-12-12 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
153,747 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-01-09 |
4 |
AS |
$96.92 |
$750,707 |
D/D |
(7,726) |
146,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-01-09 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
153,747 |
0 |
- |
|
| BHE |
Benchmark Electronics Inc |
Director |
– • – |
2020-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,883 |
19,289 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corp. Vice President & CFO |
• – – |
2006-09-08 |
4 |
OE |
$17.35 |
$145,740 |
D/D |
8,400 |
39,700 |
|
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
• – – |
2012-05-04 |
4 |
OE |
$17.14 |
$199,978 |
D/D |
8,444 |
179,465 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
• – – |
2012-05-04 |
4 |
S |
$87.03 |
$735,170 |
D/D |
(8,444) |
171,021 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,933 |
8,933 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
20,933 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
• – – |
2011-08-12 |
4 |
S |
$76.52 |
$933,511 |
D/D |
(12,200) |
183,094 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-02-01 |
4 |
OE |
$34.37 |
$466,779 |
D/D |
13,581 |
51,581 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
officerTitle |
• – – |
2006-01-31 |
4 |
OE |
$17.35 |
$242,900 |
D/D |
14,000 |
42,200 |
|
- |
|
94 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
